Your session is about to expire
← Back to Search
Neo-ASA for Argininosuccinate Lyase Deficiency
Study Summary
This trial will study the effects of a dietary supplement on cognition in patients with a rare genetic disorder.
- Argininosuccinate Lyase Deficiency
- Urea Cycle Disorders
- Urea Cycle Deficiencies
- Argininosuccinic Aciduria
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does the trial encompass minors, or are participants required to be over 18?
"As per the inclusion criteria, prospective participants must be between 6 and 50 years of age."
Is this trial presently enrolling volunteers?
"According to the details on clinicaltrials.gov, this medical trial is currently seeking participants and was initially listed in September 2017 with its last update occurring in August 2022."
What is the aggregate size of this medical study's population?
"Affirmative. According to the research available on clinicaltrials.gov, this medical investigation is currently accepting individuals for participation. The initial post was made on September 15th 2017 and updated most recently in August 5th 2022. In total 16 people across one trial site are required for enrollment."
Who is allowed to partake in this medical research?
"This clinical trial is welcoming sixteen individuals with urea cycle disorders, who are between six and fifty years of age. Furthermore, participants must provide a negative pregnancy test result, comply with the study diet and treatment plan, and agree to use an effective contraception for its entire duration (if applicable). Males enrolled in this research endeavour should also ensure their partners abide by these same contraceptive protocols."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger